Biomune preclinical data

BIME (Salt Lake City) announced results of a second animal study that showed reduction in the growth rate of prostate cancer cells.

Rats were injected with 10,000 prostate tumor cells. On the eleventh day after therapy with the immune product, animals showed no evidence of tumors, while 82 percent of rats receiving a placebo had tumors. ...